Browsing Technical documents and research evidence on COVID-19 by Title
Now showing items 841-860 of 1749
-
Infection imported virus Zika in an area settled by Aedes albopictus
(2016-06)The original source of this document may be restricted, preventing external readers from accessing the content, or it may no longer be available. Therefore, users need to use other resources to retrieve this information. -
Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected Interim guidance, 19 March 2020
(2020-03-19)Background: This is the first edition of guidance on infection prevention and control (IPC) strategies for use when COVID-19 is suspected. It has been adapted from WHO’s Infection prevention and control during health care ... -
Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, Interim guidance, 25 January 2020
Introduction: This is the first edition of guidance on infection preventionand control (IPC) strategies for use when infection with a novel coronavirus (2019-nCoV) is suspected. It has been adapted from WHO’s Infection ... -
Infection prevention and control for COVID-19: Interim guidance for home care settings
(2020-05-01)This document provides guidance specific to the COVID-19 pandemic for home care providers. Individuals responsible for policy development, implementation and oversight of infection prevention and control measures specific ... -
Infection prevention and control for COVID-19: Interim guidance for long term care homes
(2020-05-12)This document provides guidance specific to the COVID-19 pandemic in long term care homes (LTCHs). Individuals responsible for policy development, implementation and oversight of infection prevention and control measures ... -
Infection prevention and control for COVID-19: Interim guidance for outpatient and ambulatory care settings
(2020-01-30)This document provides guidance specific to the COVID-19 pandemic in outpatient and ambulatory care settings. Outpatient and ambulatory care settings are defined here as those providing health care on an outpatient basis ... -
Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19, Interim guidance 21 March 2020
(2020-03-21)Background: On 30 January 2020, WHO announced that the COVID-19 outbreak was a Public Health Emergency of International Concern. Initially, most cases were reported from China and among individuals with travel history to ... -
An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors
(2016-07)The Asian lineage of Zika virus (ZIKV) has recently caused epidemics and severe disease. Unraveling the mechanisms causing increased viral transmissibility and disease severity requires experimental systems. We report an ... -
Infectious Zika viral particles in breastmilk
(2016-06)Before 2007, no Zika virus outbreak had been recorded, and Zika virus was deemed to cause mild infections. In 2013–14, an outbreak occurred in French Polynesia associated with an increased rate of Guillain-Barré syndrome ... -
Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis
(2020-12-30)Background: Laboratory testing is commonly performed in patients with COVID-19. Each of the laboratory parameters has potential value for risk stratification and prediction of COVID-19 outcomes. This systematic review and ... -
The Influence of Contextual Factors on the Initial Phases of the COVID-19 Outbreak across U.S. Counties
(2020-05-22)Objectives: To examine the influence of county- and state-level characteristics on the initial phases of the COVID-19 outbreak across U.S. counties up to April 14, 2020. Methods: We used a statistical exponential growth ... -
The influence of the SARS-CoV-2 pandemic on esophagogastric cancer services: an international survey of esophagogastric surgeons
(2020-06-05)Background: Several guidelines to guide clinical practice among esophagogastric surgeons during the COVID-19 pandemic were produced. However, none provide reflection of current service provision. This international survey ... -
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
(2020-05-06)Urgent action is needed to fight the ongoing COVID-19 pandemic by reducing the number of infected people along with the infection contagiousness and severity. Chlorpromazine (CPZ), the prototype of typical antipsychotics ... -
Initial Clinical Impressions of the Critical Care of COVID-19 Patients in Seattle, New York City, and Chicago
(2020-03-25)Since the first recognition of a cluster of novel respiratory viral infections in China in late December 2019, intensivists in the United States have watched with growing concern as infections with the severe acute respiratory ... -
Initial Description of the Presumed Congenital Zika Syndrome
(2016-06)Objectives: To provide an initial description of the congenital syndrome presumably associated with infection by Zika virus compared with other syndromes including congenital infections of established etiologies. Methods: ... -
Initial experience with imported Zika virus infection in Spain
(2016)A considerable increase of imported Zika virus (ZIKV) infection has been reported in Europe in the last year. This is the result of the large outbreak of the disease in the Americas, along with the increase in the numbers ... -
Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic
(2020-04-15)This paper presents an analysis of risk mitigation measures taken by countries around the world facing the current COVID-19 outbreak. In light of the current pandemic the authors collated and clustered (using harmonised ...